How to buy EBOS Group shares

Own EBOS Group shares in just a few minutes.

We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!

EBOS Group Limited is a medical distribution business based in Australia. EBOS Group shares (EBO) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. EBOS Group has a trailing 12-month revenue of around $9 billion. If you're looking to buy shares, check out the steps below.

How to buy shares in EBOS Group

  1. Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
  3. Search for EBOS Group . Find the share by name or ticker symbol: EBO. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until EBOS Group reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
  6. Check in on your investment. Congratulations, you own a part of EBOS Group . Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

EBOS Group share price

Use our graph to track the performance of EBO stocks over time.

EBOS Group shares at a glance

Information last updated 2021-06-24.
52-week range$19.2122 - $32.52
50-day moving average $30.0825
200-day moving average $27.6688
Target priceN/A
PE ratio 28.2694
Dividend yield $0.773 (2.53%)
Earnings per share (TTM) $1.069

Compare share trading platforms

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.
Name Product Standard brokerage fee Inactivity fee Markets
Superhero share trading
AUD $5
No
ASX shares, ETFs
Pay zero brokerage on all Australian ETFs.
Trade ASX stocks with a flat $5 commission fee and a low minimum investment of just $100.
Bell Direct Share Trading
Finder AwardExclusive
Bell Direct Share Trading
AUD $15
No
ASX shares, mFunds, ETFs
⭐ Finder Exclusive: Get 5 free stock trades and unlimited ETF trades until July 31, 2021 when you join Bell Direct.
Bell Direct offers a one-second placement guarantee on market-to-limit ASX orders or your trade is free, plus enjoy extensive free research reports from top financial experts.
IG Share Trading
Finder Award
IG Share Trading
AUD $8 or 0.1%
$50 per quarter if you make fewer than three trades in that period
ASX shares, Global shares
$0 brokerage for US and global shares plus get an active trader discount of $5 commission on Australian shares.
Enjoy some of the lowest brokerage fees on the market when trading Australian shares, international shares, plus get access to 24-hour customer support.
Saxo Capital Markets (Classic account)
AUD $6.99
No
ASX shares, Global shares, Forex, CFDs, Margin trading, Options trading, ETFs
Acess 19,000+ stocks on 37 exchanges worldwide
Low fees for Australian and global share trading, no inactivity fees, low currency conversion fee and optimised for mobile.
CMC Markets Stockbroking
AUD $11 or 0.1%
No
ASX shares, Global shares, mFunds, ETFs
$0 brokerage on global shares including US, UK and Japan markets.
Trade up to 9,000 products, including shares, ETFs and managed funds, plus access up to 15 major global and Australian stock exchanges.
loading

Compare up to 4 providers

Is it a good time to buy EBOS Group stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

EBOS Group price performance over time

Historical closes compared with the last close of A$31.47

1 week (2021-06-17) 3.01%
1 month (2021-05-25) 3.05%
3 months (2021-03-23) 16.82%
6 months (2020-12-24) 17.34%
1 year (2020-06-24) 57.19%
3 years (2018-06-22) 89.46%
5 years (2016-06-24) 108.00%

Is EBOS Group under- or over-valued?

Valuing EBOS Group stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of EBOS Group 's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

EBOS Group 's P/E ratio

EBOS Group 's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 28x. In other words, EBOS Group shares trade at around 28x recent earnings.

That's relatively low compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

EBOS Group 's PEG ratio

EBOS Group 's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 4.2937. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into EBOS Group 's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

EBOS Group 's EBITDA

EBOS Group 's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $308.7 million.

The EBITDA is a measure of a EBOS Group 's overall financial performance and is widely used to measure a its profitability.

EBOS Group financials

Revenue TTM $9 billion
Operating margin TTM 3.03%
Gross profit TTM $917.8 million
Return on assets TTM 4.42%
Return on equity TTM 12.98%
Profit margin 1.92%
Book value 8.457
Market capitalisation $5 billion

TTM: trailing 12 months

EBOS Group share dividends

63%

Dividend payout ratio: 63.1% of net profits

Recently EBOS Group has paid out, on average, around 63.1% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.29% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), EBOS Group shareholders could enjoy a 2.29% return on their shares, in the form of dividend payments. In EBOS Group 's case, that would currently equate to about A$0.773 per share.

EBOS Group 's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.

The latest dividend was paid out to all shareholders who bought their shares by 3 March 2021 (the "ex-dividend date").

EBOS Group share price volatility

Over the last 12 months, EBOS Group 's shares have ranged in value from as little as $19.2122 up to $32.52. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while EBOS Group 's is 0.3118. This would suggest that EBOS Group 's shares are less volatile than average (for this exchange).

EBOS Group overview

EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, consumer, and animal care products in Australia and New Zealand. It operates in two segments, Healthcare and Animal Care. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and multi-brand retail pharmacy services. It also offers vitamins, minerals and supplements, herbal and fruit teas, and natural toothpastes, as well as functional foods, including molasses and manuka honey; community based health care services and programs; Pharmacy Choice, a five step integrated retail program for independent pharmacies; and healthSAVE, a community pharmacy banner that allows members drive their retail businesses. In addition, the company supplies health and wellness products public and private hospitals, day surgeries, general practice, aged care facilities, specialist clinics, government, and non-profit health agencies, as well as clinically essential products; and pharmacy services to private and public hospitals, cancer centers, correctional facilities, and veterinary clinics. Further, it offers contract logistics services, such as healthcare distribution, warehousing, clinical trial management, and product registration services; and clinical trial logistics. Additionally, the company provides pet nutrition products, treats, clean-up products, grooming, and accessories; and wholesales veterinary products for companion animals, production animals, and equine athletes. The company was formerly known as Early Bros Dental & Surgical Supplies Ltd. and changed its name to EBOS Group Limited in 1986. EBOS Group Limited was founded in 1922 and is headquartered in Docklands, Australia.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs comes with a higher risk of losing money rapidly due to leverage. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More guides on Finder

Ask an Expert

You are about to post a question on finder.com.au:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com.au is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder only provides general advice and factual information, so consider your own circumstances, or seek advice before you decide to act on our content. By submitting a question, you're accepting our Terms of Use, Disclaimer & Privacy Policy and Privacy & Cookies Policy.
Go to site
Not sure what platform to go with?
Take this quick quiz to find the right share trading platform